Article
Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
Experimental and molecular pathology - 1 Jun 2004
Akisik Elif, Dalay Nejat
Abstract excerpt
The estrogen receptor (ER) and the human epithelial growth factor receptor 2 (HER2) genes have been implicated in the development and prognosis of breast cancer. Several genetic polymorphic sites in these genes have been identified and associated with the risk of breast cancer. We have investigated the association between the estrogen receptor codon 594 (ACA to ACG) and HER2 codon 655 (ATC to GTC) polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
